Pfizer Escapes Whistleblower Suit Over Lipitor Marketing

Law360, New York (January 22, 2014, 5:42 PM EST) -- Health Support Awareness Inc. is dropping its whistleblower suit in Massachusetts federal court against Pfizer Inc. over the pharmaceutical giant’s marketing of its cholesterol drug Lipitor after the U.S. government declined to intervene in the case, the U.S. attorney's office announced Wednesday.

The U.S. attorney’s office on Wednesday consented to the dismissal of Health Support Awareness’s qui tam suit against Pfizer, court documents showed. Health Support Awareness had moved to voluntarily dismiss the suit after the U.S. attorney’s office declined to intervene in the case, according...
To view the full article, register now.




Case Information

Case Title

United States of America v. Pfizer Inc

Case Number




Nature of Suit

Other Statutes: False Claims Act


Nathaniel M. Gorton

Date Filed

August 9, 2013

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.